Tarsus Pharmaceuticals (TARS) Inventory (2023 - 2026)

Tarsus Pharmaceuticals' Inventory history runs 4 years deep, the most recent figure standing at $4.6 million for Q1 2026.

• In Q1 2026, Inventory rose 69.02% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $4.6 million (up 69.02% YoY), while the FY2025 annual figure was $4.4 million, up 66.87% from the prior year.
• Inventory for Q1 2026 stood at $4.6 million, up from $4.4 million in the prior quarter.
• The five-year high for Inventory was $4.6 million in Q1 2026, with the low at $15000.0 in Q3 2023.
• The 4-year median for Inventory is $3.1 million (2023), against an average of $3.1 million.
• The sharpest annual moves came in 2024 and 2025: Inventory surged 18873.33% in 2024, then slumped 32.98% in 2025.
• Tarsus Pharmaceuticals' Inventory stood at $3.1 million in 2023, then dropped by 15.67% to $2.6 million in 2024, then jumped by 66.87% to $4.4 million in 2025, then rose by 4.57% to $4.6 million in 2026.
• Business Quant data shows TARS's Inventory at $4.6 million in Q1 2026, $4.4 million in Q4 2025, and $3.8 million in Q3 2025.